Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-31 @ 2:08 AM
Study NCT ID:
NCT01124734
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2010-03-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma
Sponsor:
Milton S. Hershey Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-05
Start Date Type:
None
Primary Completion Date:
2017-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-04
First Submit QC Date:
None
Study First Post Date:
2010-05-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-18
Results First Submit QC Date:
None
Results First Post Date:
2019-02-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-18
Last Update Post Date:
2019-02-12
Last Update Post Date Type:
ACTUAL